비교리스트

 카트 문의
시장보고서
상품코드
1659340

세계의 정밀의료 소프트웨어 시장

Precision Medicine Software
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 89 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 정밀의료 소프트웨어 시장은 2030년까지 44억 달러에 달할 전망

2024년에 25억 달러로 추정되는 세계의 정밀의료 소프트웨어 시장은 2024-2030년에 CAGR 10.0%로 성장하며, 2030년에는 44억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 온프레미스 배포는 CAGR 9.3%를 기록하며, 분석 기간 종료시에는 26억 달러에 달할 것으로 예측됩니다. 클라우드 배포 부문의 성장률은 분석 기간 중 CAGR 11.0%로 추정됩니다.

미국 시장은 6억 3,390만 달러, 중국은 CAGR 13.4%로 성장 예측

미국의 정밀의료 소프트웨어 시장은 2024년에 6억 3,390만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 10억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 13.4%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.4%와 8.0%로 예측됩니다. 유럽에서는 독일이 CAGR 약 7.4%로 성장할 것으로 예측됩니다.

세계의 정밀의료 소프트웨어 시장 - 주요 동향과 촉진요인 정리

정밀의료 소프트웨어는 어떻게 의료를 변화시킬 것인가?

정밀의료 소프트웨어는 유전자 프로파일, 환자 이력, 환경적 요인 등 방대한 데이터를 분석하여 개인별 맞춤 치료 계획을 수립할 수 있는 툴을 제공함으로써 헬스케어를 혁신하고 있습니다. 치료가 일반화된 기존의 접근 방식과 달리, 정밀의학 소프트웨어는 환자 개개인의 특성에 맞는 중재를 수행합니다. 이러한 개인화된 접근 방식을 통해 의료진은 특정 유전자 변이를 식별하고, 치료에 대한 반응을 예측하고, 암, 심혈관 질환, 희귀 유전 질환 등의 질병에 대한 예방 및 치료 전략을 맞춤화할 수 있습니다. 이 소프트웨어는 유전체 시퀀싱, 임상 검사, 전자건강기록(EHR)의 데이터를 통합하여 의사결정을 간소화하고 환자 결과를 개선합니다. 정밀의학 소프트웨어는 개인차를 기반으로 질병 진단, 치료, 예방 능력을 강화하여 의료 서비스를 보다 정확하고 효율적이며 환자 중심으로 개선하고 있습니다.

정밀의료 소프트웨어 시장을 주도하는 기술 혁신은 무엇인가?

인공지능(AI), 빅데이터 분석, 클라우드 컴퓨팅, 유전체학의 기술 발전이 정밀의료 소프트웨어의 성장을 가속하고 있습니다. 주요 혁신 중 하나는 차세대 염기서열 분석기(NGS)와 AI 기반 소프트웨어의 통합으로 유전체 데이터의 신속하고 종합적인 분석이 가능해졌습니다는 점입니다. AI와 머신러닝 알고리즘은 여러 출처의 방대한 데이터세트를 분석하여 유전적 변이와 치료 결과의 상관관계를 밝혀냄으로써 정밀의료 용도의 질병 위험과 치료 효과에 대한 정확한 예측을 가능케 합니다. 정밀의료 용도를 통해 질병 위험과 치료 효과를 정확하게 예측할 수 있습니다.

또한 클라우드 기반 플랫폼은 의료 서비스 프로바이더가 중요한 건강 정보를 저장, 관리 및 공유하는 방식을 변화시키고 있습니다. 이러한 플랫폼은 연구자, 임상의사, 유전학자들 간의 실시간 데이터 공유와 협업을 가능하게 하여 개인 맞춤형 치료법 발견을 크게 앞당길 수 있습니다. 웨어러블 기기 및 원격 모니터링 툴의 데이터를 통합할 수 있게 됨으로써 진단과 치료의 정확도를 더욱 높이고, 장기적으로 환자의 건강 상태를 보다 종합적으로 파악할 수 있게 되었습니다. 이러한 기술의 결합으로 헬스케어 시스템은 환자 치료에 보다 데이터 중심적이고 정확하며 예측적인 접근 방식을 채택할 수 있게 되었습니다.

규제 지원과 업계 협업이 정밀의료 소프트웨어 시장을 어떻게 형성하고 있는가?

정부 구상과 업계 협업은 정밀의료 소프트웨어 시장을 촉진하는 중요한 요소입니다. 미국 식품의약국(FDA)과 같은 규제기관은 정밀 치료 및 진단 툴의 승인을 신속하게 진행할 수 있는 길을 만들고 있습니다. 예를 들어 유전자 프로파일을 기반으로 환자를 표적 치료제에 맞게 조정하는 데 필수적인 동반 진단 툴은 보다 신속한 규제 절차를 통해 지원되고 있습니다. 미국의 정밀의학 구상(Precision Medicine Initiative)나 유럽의 호라이즌 2020(Horizon 2020) 프로그램과 같은 구상은 연구, 혁신, 정밀의학의 임상 통합을 촉진하기 위해 많은 자금을 배정하고 있습니다.

또한 제약사, 생명공학 기업, 기술 프로바이더 간의 협력은 정밀의료 소프트웨어 개발에 박차를 가하고 있습니다. 이러한 파트너십은 임상 연구, 유전체 데이터, 머신러닝 알고리즘의 통합을 촉진하여 새로운 바이오마커와 개인화된 치료법을 발견할 수 있도록 돕습니다. 또한 많은 주요 헬스케어 기업이 AI 기업과 협력하여 진단 및 치료 능력을 향상시키고 있습니다. 이러한 노력으로 보다 통합된 헬스케어 생태계가 구축되고 있으며, 정밀의료 소프트웨어는 맞춤형 의료를 촉진하는 데 있으며, 핵심적인 역할을 하고 있습니다.

정밀의료 소프트웨어 시장의 주요 성장 동력은 무엇인가?

정밀의료 소프트웨어 시장의 성장에는 만성질환 증가, 유전체학의 발전, 개인화된 헬스케어에 대한 소비자의 니즈 증가 등 여러 가지 요인이 기여하고 있습니다. 암, 심혈관 질환, 유전성 질환의 발병률이 증가함에 따라 의료 서비스 프로바이더는 보다 효과적인 표적 치료를 요구하고 있습니다. 정밀의학 소프트웨어는 유전체 프로파일링 및 예측 분석을 위한 툴을 제공함으로써 임상의가 맞춤형 치료 계획을 세우고, 더 나은 결과를 가져오고, 약물 처방의 시행착오를 줄일 수 있도록 돕습니다.

또 다른 주요 성장 요인은 유전체 시퀀싱의 지속적인 비용 절감으로 더 많은 환자 집단이 맞춤형 의료를 더 쉽게 이용할 수 있게 되었습니다. 유전자 검사가 저렴해짐에 따라 의료 서비스 프로바이더들은 점점 더 많은 유전체 데이터를 일상적인 임상에 도입하고 있습니다. 이러한 추세는 데이터 분석의 속도와 정확성을 향상시키는 AI 기술 혁신에 힘입어 더욱 가속화되고 있습니다.

또한 가치 기반 진료 모델이 강조되면서 정밀의료 소프트웨어의 도입이 가속화되고 있습니다. 의료시스템은 비용 절감과 함께 환자의 치료 결과를 개선하는 데 초점을 맞추며 볼륨 기반에서 가치 기반 치료로 전환하고 있습니다. 정밀의료는 보다 정확한 진단과 맞춤형 치료를 제공함으로써 이러한 목표에 부합하고 불필요한 치료와 입원의 필요성을 줄여줍니다. 이러한 요인에 더해 헬스케어 분야에서 빅데이터 분석과 클라우드 컴퓨팅의 활용도가 높아짐에 따라 향후 수년간 정밀의료 소프트웨어 시장의 강력한 성장을 가속할 것으로 예상됩니다.

부문

배포(온프레미스, 클라우드); 용도(종양학, 약물유전체학, 희귀질환, 기타 용도); 최종사용처(의료 제공자, 연구센터 및 학술기관, 제약 및 바이오테크놀러지 기업, 기타 최종사용처)

조사 대상 기업의 예(총 34건)

  • 2bprecise, LLC
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42, Inc.
  • Human Longevity, Inc.
  • Lifeomic Health, LLC
  • N-Of-One, Inc.(A Subsidiary of Qiagen N.V.)
  • Pieriandx, Inc.
  • Sophia Genetics Sa
  • Sunquest Information Systems, Inc.
  • Syapse, Inc.
  • Translational Software Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.03.07

Global Precision Medicine Software Market to Reach US$4.4 Billion by 2030

The global market for Precision Medicine Software estimated at US$2.5 Billion in the year 2024, is expected to reach US$4.4 Billion by 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Cloud Deployment segment is estimated at 11.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$633.9 Million While China is Forecast to Grow at 13.4% CAGR

The Precision Medicine Software market in the U.S. is estimated at US$633.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 13.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.

Global Precision Medicine Software Market - Key Trends & Drivers Summarized

How Is Precision Medicine Software Transforming Healthcare?

Precision medicine software is transforming healthcare by providing tools to analyze vast amounts of data—such as genetic profiles, patient histories, and environmental factors—to develop individualized treatment plans. Unlike traditional approaches, where treatments are generalized, precision medicine software tailors interventions to the unique characteristics of each patient. This personalized approach enables healthcare providers to identify specific genetic mutations, predict responses to therapies, and customize prevention and treatment strategies for diseases like cancer, cardiovascular disorders, and rare genetic conditions. The software integrates data from genomic sequencing, laboratory tests, and electronic health records (EHRs), streamlining decision-making and improving patient outcomes. By enhancing the ability to diagnose, treat, and prevent diseases based on individual variability, precision medicine software is making healthcare more accurate, efficient, and patient-centered.

What Technological Innovations Are Driving the Precision Medicine Software Market?

Technological advancements in artificial intelligence (AI), big data analytics, cloud computing, and genomics are driving the growth of precision medicine software. One of the key innovations is the integration of next-generation sequencing (NGS) with AI-powered software, allowing for fast and comprehensive analysis of genomic data. This technology helps identify actionable biomarkers that guide personalized treatments, especially in fields like oncology. AI and machine learning algorithms analyze vast datasets from multiple sources to reveal correlations between genetic variations and treatment outcomes, enabling precision medicine applications to predict disease risks and the effectiveness of therapies more accurately.

Additionally, cloud-based platforms are transforming how healthcare providers store, manage, and share critical health information. These platforms allow for real-time data sharing and collaboration between researchers, clinicians, and geneticists, significantly accelerating the discovery of personalized treatments. The ability to integrate data from wearable devices and remote monitoring tools further enhances the precision of diagnosis and treatment, offering a more comprehensive view of patient health over time. The convergence of these technologies is enabling healthcare systems to adopt more data-driven, precise, and predictive approaches to patient care.

How Are Regulatory Support and Industry Collaborations Shaping the Precision Medicine Software Market?

Government initiatives and industry collaborations are key factors driving the precision medicine software market. Regulatory bodies, such as the U.S. Food and Drug Administration (FDA), have created pathways to fast-track the approval of precision therapies and diagnostic tools. For instance, companion diagnostics, which are essential in matching patients to targeted therapies based on their genetic profiles, are being supported through faster regulatory processes. Initiatives like the U.S. Precision Medicine Initiative and Europe's Horizon 2020 program have allocated substantial funding to promote research, innovation, and the integration of precision medicine into clinical practice.

Furthermore, collaborations between pharmaceutical companies, biotechnology firms, and technology providers are fueling the development of precision medicine software. These partnerships facilitate the integration of clinical research, genomic data, and machine learning algorithms to discover new biomarkers and personalized treatments. Many leading healthcare organizations are also collaborating with AI companies to enhance their diagnostic and therapeutic capabilities. These efforts are creating a more integrated healthcare ecosystem where precision medicine software plays a central role in advancing personalized healthcare.

What Are the Key Growth Drivers in the Precision Medicine Software Market?

Several factors are contributing to the growth of the precision medicine software market, including the increasing prevalence of chronic diseases, advancements in genomics, and growing consumer demand for personalized healthcare. The rising incidence of cancer, cardiovascular diseases, and genetic disorders is prompting healthcare providers to seek more effective, targeted therapies. Precision medicine software, by offering tools for genomic profiling and predictive analytics, enables clinicians to develop tailored treatment plans, leading to better outcomes and reduced trial-and-error in prescribing medications.

Another major growth driver is the continued reduction in the cost of genomic sequencing, making personalized medicine more accessible to larger patient populations. As genetic testing becomes more affordable, healthcare providers are increasingly incorporating genomic data into routine clinical practice. This trend is further supported by technological innovations in AI, which improve the speed and accuracy of data analysis.

In addition, the growing emphasis on value-based care models is accelerating the adoption of precision medicine software. Healthcare systems are shifting from volume-based to value-based care, focusing on improving patient outcomes while reducing costs. Precision medicine, by offering more precise diagnoses and personalized treatments, aligns with these goals, reducing the need for unnecessary treatments and hospitalizations. These factors, along with the increasing availability of big data analytics and cloud computing in healthcare, are expected to drive strong growth in the precision medicine software market in the coming years.

SCOPE OF STUDY:

The report analyzes the Precision Medicine Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (On-Premise, Cloud); Application (Oncology, Pharmacogenomics, Rare Diseases, Other Applications); End-Use (Healthcare Providers, Research Centers & Academic Institutes, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • 2bprecise, LLC
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Gene42, Inc.
  • Human Longevity, Inc.
  • Lifeomic Health, LLC
  • N-Of-One, Inc. (A Subsidiary of Qiagen N.V.)
  • Pieriandx, Inc.
  • Sophia Genetics Sa
  • Sunquest Information Systems, Inc.
  • Syapse, Inc.
  • Translational Software Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Precision Medicine Software - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Adoption of Genomic Data Analysis Software Spurs Growth in Precision Medicine Software Market
    • Advancements in AI and Machine Learning Propel Demand for Precision Medicine Software for Predictive Analytics
    • Rising Focus on Personalized Healthcare Expands Addressable Market Opportunity for Precision Medicine Software Solutions
    • Growth of Direct-to-Consumer Genetic Testing Drives Adoption of Precision Medicine Software for Data Management
    • Integration of Multi-Omics Data Strengthens the Business Case for Advanced Precision Medicine Software Platforms
    • Increasing Use of Real-World Evidence (RWE) in Clinical Research Generates Demand for Precision Medicine Software Tools
    • Expansion of Bioinformatics Capabilities Drives Adoption of Precision Medicine Software for Complex Data Interpretation
    • Rising Demand for Cloud-Based Solutions Strengthens Adoption of Precision Medicine Software in Healthcare Settings
    • Technological Advancements in Electronic Health Records (EHR) Integration Drive Growth in Precision Medicine Software
    • Growing Investment in Personalized Therapeutics Fuels Demand for Precision Medicine Software for Drug Development
    • Increasing Use of Wearable Devices and Health Sensors Expands Opportunities for Precision Medicine Software to Integrate Real-Time Data
    • Development of Next-Generation Sequencing (NGS) Technologies Drives Adoption of Precision Medicine Software for Genomic Interpretation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Precision Medicine Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Precision Medicine Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Research Centers & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Research Centers & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Pharmacogenomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Pharmacogenomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Rare Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Rare Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Rare Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 34: World Precision Medicine Software Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Precision Medicine Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Precision Medicine Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Precision Medicine Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Precision Medicine Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Precision Medicine Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Precision Medicine Software by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Precision Medicine Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Precision Medicine Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Precision Medicine Software by Deployment - On-Premise and Cloud Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Precision Medicine Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Precision Medicine Software by End-Use - Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Precision Medicine Software by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Healthcare Providers, Research Centers & Academic Institutes and Pharma & Biotech Companies for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Precision Medicine Software by Application - Oncology, Pharmacogenomics, Rare Diseases and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Precision Medicine Software by Application - Percentage Breakdown of Value Sales for Oncology, Pharmacogenomics, Rare Diseases and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제